HHS Panel updates Microsporidiosis Section of OI Guidelines

The Microsporidiosis Section of the HHS Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV has been updated with information on microsporidia that have been documented in human infections, their taxonomy, data on the use of nitazoxanide for the treatment of microsporidiosis and the availability of fumagillin for the treatment of Enterocytozoon bieneusi infection, with contact information for obtaining the medication from Sanofi.

In case you missed it, the HHS panel updated the name of the guidelines in May, to the current, person-first, Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV, from the previous Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-infected Adults and Adolescents.